Koch C - Search Results

1

Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.

Skov M, Koch C, Reimert CM, Poulsen LK. Skov M, et al. Among authors: koch c. Allergy. 2000 Jan;55(1):50-8. doi: 10.1034/j.1398-9995.2000.00342.x. Allergy. 2000. PMID: 10696856

2

Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.

Skov M, McKay K, Koch C, Cooper PJ. Skov M, et al. Among authors: koch c. Respir Med. 2005 Jul;99(7):887-93. doi: 10.1016/j.rmed.2004.11.018. Epub 2005 Jan 26. Respir Med. 2005. PMID: 15939251 Free article.

3

Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.

Bisgaard H, Pedersen SS, Nielsen KG, Skov M, Laursen EM, Kronborg G, Reimert CM, Høiby N, Koch C. Bisgaard H, et al. Among authors: koch c. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1190-6. doi: 10.1164/ajrccm.156.4.9612044. Am J Respir Crit Care Med. 1997. PMID: 9351621 Clinical Trial.

4

Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis.

Skov M, Poulsen LK, Koch C. Skov M, et al. Among authors: koch c. Pediatr Pulmonol. 1999 Feb;27(2):74-9. doi: 10.1002/(sici)1099-0496(199902)27:2<74::aid-ppul2>3.0.co;2-l. Pediatr Pulmonol. 1999. PMID: 10088929

5

Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA).

Skov M, Pressler T, Jensen HE, Høiby N, Koch C. Skov M, et al. Among authors: koch c. Thorax. 1999 Jan;54(1):44-50. doi: 10.1136/thx.54.1.44. Thorax. 1999. PMID: 10343631 Free PMC article.

6

Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Skov M, Høiby N, Koch C. Skov M, et al. Among authors: koch c. Allergy. 2002 Aug;57(8):723-8. doi: 10.1034/j.1398-9995.2002.23583.x. Allergy. 2002. PMID: 12121192

7

Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients.

Skov M, Pandey JP, Pressler T, Høiby N, Koch C. Skov M, et al. Among authors: koch c. J Cyst Fibros. 2004 Aug;3(3):173-8. doi: 10.1016/j.jcf.2004.05.048. J Cyst Fibros. 2004. PMID: 15463904 Free article.

8

Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

Main KM, Skov M, Sillesen IB, Dige-Petersen H, Müller J, Koch C, Lanng S. Main KM, et al. Among authors: koch c. Acta Paediatr. 2002;91(9):1008-11. doi: 10.1080/080352502760272759. Acta Paediatr. 2002. PMID: 12412882

9

Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.

Pressler T, Frederiksen B, Skov M, Garred P, Koch C, Høiby N. Pressler T, et al. Among authors: koch c. J Cyst Fibros. 2006 Jan;5(1):9-15. doi: 10.1016/j.jcf.2005.11.002. Epub 2006 Jan 10. J Cyst Fibros. 2006. PMID: 16412706 Free article.

10

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide.

Skov M, Main KM, Sillesen IB, Müller J, Koch C, Lanng S. Skov M, et al. Among authors: koch c. Eur Respir J. 2002 Jul;20(1):127-33. doi: 10.1183/09031936.02.00248002. Eur Respir J. 2002. PMID: 12166560 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,687 results

Search Page

Filters